Almac Diagnostics, EORTC Collaborate to Establish Molecular Profiles for Cancer Patients

Press/Media: Research

Description

Almac Diagnostics has announced that the European Organization for the Research and Treatment of Cancer (EORTC) has tapped the company to establish molecular profiles of cancer patient samples.

The EORTC, with help from Almac Diagnostics laboratory services, seeks to streamline patient inclusion in clinical trials of molecularly targeted treatments, and to standardize next-generation sequencing and gene expression analysis

Period08 Mar 2017

Media contributions

1

Media contributions

  • TitleAlmac Diagnostics, EORTC Collaborate to Establish Molecular Profiles for Cancer Patients
    Degree of recognitionInternational
    Media name/outletGenome Web
    Media typePrint
    CountryUnited Kingdom
    Date08/03/2017
    DescriptionAlmac Diagnostics has announced that the European Organization for the Research and Treatment of Cancer (EORTC) has tapped the company to establish molecular profiles of cancer patient samples.
    The EORTC, with help from Almac Diagnostics laboratory services, seeks to streamline patient inclusion in clinical trials of molecularly targeted treatments, and to standardize next-generation sequencing and gene expression analysis
    URLhttps://www.genomeweb.com/sequencing/almac-diagnostics-eortc-collaborate-establish-molecular-profiles-cancer-patients#.WruNBaqWyM8
    PersonsPaul Harkin